Media headlines about Wright Medical Group N.V. (NASDAQ:WMGI) have trended positive recently, Accern Sentiment Analysis reports. The research group rates the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Wright Medical Group N.V. earned a coverage optimism score of 0.36 on Accern’s scale. Accern also assigned media headlines about the medical device company an impact score of 46.8903298129343 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
These are some of the media headlines that may have effected Accern Sentiment Analysis’s scoring:
- Jefferies Group LLC Reiterates Buy Rating for Wright Medical Group N.V. (WMGI) (americanbankingnews.com)
- BMO Capital Markets Cuts Wright Medical Group N.V. (WMGI) Price Target to $31.00 (americanbankingnews.com)
- Wright Medical Group N.V. (WMGI) Price Target Lowered to $30.00 at Barclays PLC (americanbankingnews.com)
- Royal Bank Of Canada Reiterates “Buy” Rating for Wright Medical Group N.V. (WMGI) (americanbankingnews.com)
- Wright Medical Group N.V. Reports 2017 Third Quarter Financial Results and Updated 2017 Annual Guidance (finance.yahoo.com)
Shares of Wright Medical Group N.V. (WMGI) traded up $0.51 during midday trading on Friday, reaching $24.56. The company had a trading volume of 2,120,000 shares, compared to its average volume of 996,967. Wright Medical Group N.V. has a 52-week low of $20.69 and a 52-week high of $31.53. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.45 and a quick ratio of 1.12.
Wright Medical Group N.V. (NASDAQ:WMGI) last announced its quarterly earnings results on Wednesday, November 1st. The medical device company reported ($0.16) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.16). Wright Medical Group N.V. had a negative return on equity of 5.99% and a negative net margin of 38.40%. The firm had revenue of $170.50 million during the quarter, compared to the consensus estimate of $173.50 million. During the same period in the prior year, the firm earned ($0.19) EPS. The firm’s quarterly revenue was up 8.4% compared to the same quarter last year. analysts forecast that Wright Medical Group N.V. will post -0.28 earnings per share for the current year.
WMGI has been the subject of a number of research analyst reports. Jefferies Group LLC restated a “buy” rating and set a $33.00 price objective on shares of Wright Medical Group N.V. in a report on Thursday, October 12th. Oppenheimer Holdings, Inc. set a $30.00 price objective on Wright Medical Group N.V. and gave the stock a “hold” rating in a report on Thursday, August 3rd. Robert W. Baird restated a “buy” rating and set a $33.00 price objective on shares of Wright Medical Group N.V. in a report on Friday, October 6th. Royal Bank Of Canada restated a “buy” rating and set a $31.00 price objective on shares of Wright Medical Group N.V. in a report on Tuesday, October 3rd. Finally, Needham & Company LLC restated a “hold” rating on shares of Wright Medical Group N.V. in a report on Friday, September 1st. Six analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Wright Medical Group N.V. currently has an average rating of “Buy” and a consensus price target of $32.22.
WARNING: “Wright Medical Group N.V. (WMGI) Given Daily Media Impact Rating of 0.36” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at https://www.com-unik.info/2017/11/04/wright-medical-group-n-v-wmgi-given-daily-media-impact-rating-of-0-36.html.
Wright Medical Group N.V. Company Profile
Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.
What are top analysts saying about Wright Medical Group N.V.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Wright Medical Group N.V. and related companies.